Pediatric Cardiology

, Volume 38, Issue 7, pp 1523–1524 | Cite as

Future Applications of the Selective Prostacyclin (IP) Receptor Agonist Selexipag in Pediatric Pulmonary Hypertension

Letter To The Editor

Notes

Compliance with Ethical Standards

Confilct of interest

The authors declare that there was no financial support that might pose a conflict of interest in connection with the submitted article.

Research Involving Human and Animal Participants

This letter does not include any research involving human participants and/or animals.

Informed Consent

Informed consent has not been obtained as such consent is not applicable for this article.

References

  1. 1.
    Gallotti R, Drogalis-Kim DE, Satou G, Alejos J (2017) Single-center experience using selexipag in a pediatric population. Pediatr Cardiol. doi: 10.1007/s00246-017-1677-7 PubMedGoogle Scholar
  2. 2.
    Hansmann G, Apitz C (2016) Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart 102(Suppl 2):ii67–85CrossRefPubMedGoogle Scholar
  3. 3.
    Ewert R, Richter MJ, Steringer-Mascherbauer R, Grünig E, Lange TJ, Opitz CF et al (2017) Intravenous treprostinil infusion via a fully implantable pump for pulmonary arterial hypertension. Clin Res Cardiol. doi: 10.1007/s00392-017-1114-1 Google Scholar
  4. 4.
    Geerdink LM, Bertram H, Hansmann G (2017) First-in-child use of the oral selective prostacyclin IP receptor agonist selexipag in pulmonary arterial hypertension. Pulm Circ 7:551–554CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Hansmann G, Apitz C (2016) The need for comprehensive cardiac catheterization in children with pulmonary hypertension. J Am Coll Cardiol 67:1009–1010CrossRefPubMedGoogle Scholar
  6. 6.
    Hansmann G (2017) Pulmonary hypertension in infants, children, and young adults. J Am Coll Cardiol 69:2551–2569CrossRefPubMedGoogle Scholar
  7. 7.
    Koestenberger M, Apitz C, Abdul-Khaliq H, Hansmann G (2016) Transthoracic echocardiography for the evaluation of children and adolescents with suspected or confirmed pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart 102(Suppl 2):ii14–22CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Division of Pediatric Cardiology, Department of PediatricsMedical University GrazGrazAustria
  2. 2.Department of Pediatric Cardiology and Critical CareHannover Medical SchoolHannoverGermany

Personalised recommendations